iHuman Inc. Sponsored ADR (NYSE:IH - Get Free Report) declared an annual dividend on Tuesday, March 31st. Stockholders of record on Friday, April 17th will be paid a dividend of 0.10 per share on Friday, May 15th. This represents a dividend yield of 616.0%. The ex-dividend date is Friday, April 17th.
iHuman Stock Performance
Shares of IH opened at $1.75 on Wednesday. iHuman has a 52-week low of $1.55 and a 52-week high of $3.60. The business's fifty day moving average is $1.81 and its 200-day moving average is $2.22. The firm has a market cap of $89.44 million, a price-to-earnings ratio of 7.00 and a beta of 0.13.
iHuman (NYSE:IH - Get Free Report) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $0.04 earnings per share (EPS) for the quarter. iHuman had a return on equity of 9.79% and a net margin of 11.80%.The company had revenue of $27.25 million for the quarter.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings lowered iHuman from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, January 26th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, iHuman currently has an average rating of "Sell".
View Our Latest Stock Analysis on IH
iHuman Company Profile
(
Get Free Report)
iHuman Inc provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, iHuman Writing, iHuman Fantastic Friends, and iHuman Readers; bekids Coding, bekids Coloring, bekids Reading, bekids Puzzle, bekids Academy, and Gogo Town; and Aha World, an open-ended interactive app that nurtures a desire for discovery.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider iHuman, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iHuman wasn't on the list.
While iHuman currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.